ProMIS Neurosciences Inc. - Common Shares (NQ:PMN)

6.990 -0.370 (-5.03%)

Streaming Delayed Price Updated: 3:59 PM EST, Dec 30, 2025 Add to My Watchlist

Price and Volume

Volume	29,283
Open	7.380
Bid (Size)	6.950 (100)
Ask (Size)	7.250 (200)
Prev. Close	7.360
Today's Range	6.820 - 7.540
52wk Range	6.270 - 39.75
Shares Outstanding	32,689,190
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

ProMIS Neurosciences Exceeds Target Enrollment in PRECISE-AD Phase 1b Clinical Trial of PMN310 in Alzheimer’s Disease

December 18, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

ProMIS Neurosciences Announces New Peer-Reviewed Publication Highlighting Selective Targeting of Toxic Oligomers for Potential Clinical Benefit and Reduced ARIA Risk

December 10, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

Performance

YTD	-70.9%	-70.9%
1 Month	-0.1%	-0.1%
3 Month	-36.5%	-36.5%
6 Month	-42.2%	-42.2%
1 Year	-69.0%	-69.0%

More News

ProMIS Neurosciences Announces New Peer-Reviewed Publication Showing Plasma pTau as a Predictive Early Endpoint in Alzheimer’s trials, Supporting its Ongoing Phase 1b PRECISE-AD trial with PMN310

December 01, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

ProMIS Neurosciences to Participate in the 8th Annual Evercore Healthcare Conference

December 01, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

Which stocks are experiencing notable movement on Monday? ↗

November 24, 2025

Via Chartmill

Top movers in Monday's session ↗

November 24, 2025

Via Chartmill

The market is filled with gapping stocks in Monday's session. ↗

November 24, 2025

Via Chartmill

Wondering what's happening in today's pre-market session? ↗

November 24, 2025

Via Chartmill

ProMIS Neurosciences Announces Reverse Stock Split

November 24, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

November 19, 2025

Via Benzinga

ProMIS Neurosciences Announces Third Quarter 2025 Financial Results & Corporate Highlights

November 12, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

ProMIS Neurosciences to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

November 03, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

ProMIS Neurosciences Strengthens Board with Appointment of Slanix Paul Alex, Pharm.D., President and Portfolio Manager, Public Equity of Ally Bridge Group

October 22, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

September 05, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

September 05, 2025

Via Benzinga

ProMIS Neurosciences Receives DSMB Approval to Advance to Final Dose Escalation Cohort in Phase 1b Alzheimer’s Trial of PMN310

September 03, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

ProMIS Neurosciences Announces Second Quarter 2025 Financial Results & Corporate Highlights

August 13, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

EXCLUSIVE: July's 20 Most-Searched Tickers On Benzinga Pro — Where Do Opendoor, Nvidia, Apple Stock Rank? ↗

August 01, 2025

Via Benzinga

ProMIS Neurosciences to Showcase Protein-Misfolding Drug Discovery Platform & PRECISE-AD Trial Design at the 2025 Alzheimer’s Association International Conference

July 29, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

What's going on in today's pre-market session ↗

July 28, 2025

Via Chartmill

ProMIS Neurosciences Announces Private Placement Financing

July 28, 2025

From ProMIS Neurosciences Inc.

Via GlobeNewswire

Why Vicor Shares Are Trading Higher By 39%; Here Are 20 Stocks Moving Premarket ↗

July 23, 2025

Via Benzinga

Which stocks are experiencing notable movement on Tuesday? ↗

July 22, 2025

Via Chartmill

Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗

July 22, 2025

Via Chartmill

Gapping stocks in Tuesday's session ↗

July 22, 2025

Via Chartmill

Frequently Asked Questions

Is ProMIS Neurosciences Inc. - Common Shares publicly traded?

Yes, ProMIS Neurosciences Inc. - Common Shares is publicly traded.

What exchange does ProMIS Neurosciences Inc. - Common Shares trade on?

ProMIS Neurosciences Inc. - Common Shares trades on the Nasdaq Stock Market

What is the ticker symbol for ProMIS Neurosciences Inc. - Common Shares?

The ticker symbol for ProMIS Neurosciences Inc. - Common Shares is PMN on the Nasdaq Stock Market

What is the current price of ProMIS Neurosciences Inc. - Common Shares?

The current price of ProMIS Neurosciences Inc. - Common Shares is 6.990

When was ProMIS Neurosciences Inc. - Common Shares last traded?

The last trade of ProMIS Neurosciences Inc. - Common Shares was at 12/30/25 03:59 PM ET

What is the market capitalization of ProMIS Neurosciences Inc. - Common Shares?

The market capitalization of ProMIS Neurosciences Inc. - Common Shares is 228.50M

How many shares of ProMIS Neurosciences Inc. - Common Shares are outstanding?

ProMIS Neurosciences Inc. - Common Shares has 228M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.